Elevated systemic inflammation level increases the risk of incident cancer mortality among patients with coronary artery disease

Inflammation-Related Biomarkers for the Prediction of Prognosis in Colorectal Cancer Patients

(2021) Takehito Yamamoto et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Overall and Cause-Specific Mortality in Randomized Clinical Trials Comparing Percutaneous Interventions With Coronary Bypass Surgery

(2020) Mario Gaudino et al.   JAMA Internal Medicine

Inflammation and Cancer: Triggers, Mechanisms, and Consequences

(2019) Florian R. Greten et al.   IMMUNITY

Noncardiac Versus Cardiac Mortality in Heart Failure With Preserved, Midrange, and Reduced Ejection Fraction

(2019) Giuseppe Vergaro et al.   Journal of the American Heart Association

Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial

(2017) Paul M Ridker et al.   LANCET

Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015

(2016) Haidong Wang et al.   LANCET

Novel Inflammatory Biomarkers in Coronary Artery Disease: Potential Therapeutic Approaches

(2015) Konstantinos Voudris et al.   CURRENT MEDICINAL CHEMISTRY

Baseline C-Reactive Protein Is Associated With Incident Cancer and Survival in Patients With Cancer

(2009) Kristine H. Allin et al.   JOURNAL OF CLINICAL ONCOLOGY